324 related articles for article (PubMed ID: 10905593)
1. Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3.
Rubbia-Brandt L; Quadri R; Abid K; Giostra E; Malé PJ; Mentha G; Spahr L; Zarski JP; Borisch B; Hadengue A; Negro F
J Hepatol; 2000 Jul; 33(1):106-15. PubMed ID: 10905593
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte steatosis is an important predictor of response to interferon (IFN) monotherapy in Japanese patients infected with HCV genotype 2a: Virological features of IFN-resistant cases with hepatocyte steatosis.
Akuta N; Suzuki F; Suzuki Y; Sezaki H; Hosaka T; Someya T; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kobayashi M; Kumada H
J Med Virol; 2005 Apr; 75(4):550-8. PubMed ID: 15714492
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.
Petit JM; Benichou M; Duvillard L; Jooste V; Bour JB; Minello A; Verges B; Brun JM; Gambert P; Hillon P
Am J Gastroenterol; 2003 May; 98(5):1150-4. PubMed ID: 12809841
[TBL] [Abstract][Full Text] [Related]
4. Effect of antiviral treatment on evolution of liver steatosis in patients with chronic hepatitis C: indirect evidence of a role of hepatitis C virus genotype 3 in steatosis.
Castéra L; Hézode C; Roudot-Thoraval F; Lonjon I; Zafrani ES; Pawlotsky JM; Dhumeaux D
Gut; 2004 Mar; 53(3):420-4. PubMed ID: 14960527
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus infection and liver steatosis.
Ramalho F
Antiviral Res; 2003 Oct; 60(2):125-7. PubMed ID: 14638408
[TBL] [Abstract][Full Text] [Related]
6. Impact of hepatic steatosis on viral kinetics and treatment outcome during antiviral treatment of chronic HCV infection.
Westin J; Lagging M; Dhillon AP; Norkrans G; Romero AI; Pawlotsky JM; Zeuzem S; Schalm SW; Verheij-Hart E; Negro F; Missale G; Neumann AU; Hellstrand K;
J Viral Hepat; 2007 Jan; 14(1):29-35. PubMed ID: 17212641
[TBL] [Abstract][Full Text] [Related]
7. The impact of fibrosis and steatosis on early viral kinetics in HCV genotype 1-infected patients treated with Peg-IFN-alfa-2a and ribavirin.
Guedj H; Guedj J; Negro F; Lagging M; Westin J; Bochud PY; Bibert S; Neumann AU;
J Viral Hepat; 2012 Jul; 19(7):488-96. PubMed ID: 22676361
[TBL] [Abstract][Full Text] [Related]
8. Morphological changes in intracellular lipid droplets induced by different hepatitis C virus genotype core sequences and relationship with steatosis.
Piodi A; Chouteau P; Lerat H; Hézode C; Pawlotsky JM
Hepatology; 2008 Jul; 48(1):16-27. PubMed ID: 18570290
[TBL] [Abstract][Full Text] [Related]
9. Impact of amino acid substitutions in the hepatitis C virus genotype 1b core region on liver steatosis and hepatic oxidative stress in patients with chronic hepatitis C.
Tachi Y; Katano Y; Honda T; Hayashi K; Ishigami M; Itoh A; Hirooka Y; Nakano I; Samejima Y; Goto H
Liver Int; 2010 Apr; 30(4):554-9. PubMed ID: 19951380
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms and significance of liver steatosis in hepatitis C virus infection.
Negro F
World J Gastroenterol; 2006 Nov; 12(42):6756-65. PubMed ID: 17106922
[TBL] [Abstract][Full Text] [Related]
11. Correlation of serum adiponectin levels and hepatic steatosis in hepatitis C virus genotype 1 infection.
Kara B; Gunesacar R; Doran F; Kara IO; Akkiz H
Adv Ther; 2007; 24(5):972-82. PubMed ID: 18029322
[TBL] [Abstract][Full Text] [Related]
12. The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients.
Patton HM; Patel K; Behling C; Bylund D; Blatt LM; Vallée M; Heaton S; Conrad A; Pockros PJ; McHutchison JG
J Hepatol; 2004 Mar; 40(3):484-90. PubMed ID: 15123364
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular fat accumulation and low serum cholesterol in patients infected with HCV-3a.
Hofer H; Bankl HC; Wrba F; Steindl-Munda P; Peck-Radosavljevic M; Osterreicher C; Mueller C; Gangl A; Ferenci P
Am J Gastroenterol; 2002 Nov; 97(11):2880-5. PubMed ID: 12425563
[TBL] [Abstract][Full Text] [Related]
14. Serum leptin and ghrelin in chronic hepatitis C patients with steatosis.
Pavlidis C; Panoutsopoulos GI; Tiniakos D; Koutsounas S; Vlachogiannakos J; Zouboulis-Vafiadis I
World J Gastroenterol; 2011 Dec; 17(46):5097-104. PubMed ID: 22171144
[TBL] [Abstract][Full Text] [Related]
15. Specific polymorphisms in hepatitis C virus genotype 3 core protein associated with intracellular lipid accumulation.
Jhaveri R; McHutchison J; Patel K; Qiang G; Diehl AM
J Infect Dis; 2008 Jan; 197(2):283-91. PubMed ID: 18177246
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus-induced steatosis: an overview.
Negro F
Dig Dis; 2010; 28(1):294-9. PubMed ID: 20460926
[TBL] [Abstract][Full Text] [Related]
17. Serum HCV RNA levels correlate with histological liver damage and concur with steatosis in progression of chronic hepatitis C.
Adinolfi LE; Utili R; Andreana A; Tripodi MF; Marracino M; Gambardella M; Giordano M; Ruggiero G
Dig Dis Sci; 2001 Aug; 46(8):1677-83. PubMed ID: 11508667
[TBL] [Abstract][Full Text] [Related]
18. Liver steatosis in chronic hepatitis C: a morphological sign suggesting infection with HCV genotype 3.
Rubbia-Brandt L; Leandro G; Spahr L; Giostra E; Quadri R; Malé PJ; Negro F
Histopathology; 2001 Aug; 39(2):119-24. PubMed ID: 11493327
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus genotype 3 is cytopathic to hepatocytes: Reversal of hepatic steatosis after sustained therapeutic response.
Kumar D; Farrell GC; Fung C; George J
Hepatology; 2002 Nov; 36(5):1266-72. PubMed ID: 12395339
[TBL] [Abstract][Full Text] [Related]
20. Different mechanisms of steatosis in hepatitis C virus genotypes 1 and 3 infections.
Hézode C; Roudot-Thoraval F; Zafrani ES; Dhumeaux D; Pawlotsky JM
J Viral Hepat; 2004 Sep; 11(5):455-8. PubMed ID: 15357652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
